Prognostic significance of RB1-inducible coiled-coil 1 in salivary gland cancers

Head and Neck

Volumn 34, Issue 5, 2012, Pages 674-680

  Tameno, Hitosuke ^a,b   Chano, Tokuhiro ^a   Ikebuchi, Kaichiro ^a,b   Ochi, Yasuko ^a,b   Arai, Akihito ^a,b   Kishimoto, Mitsuo ^b   Shimada, Taketoshi ^b   Hisa, Yasuo ^b   Okabe, Hidetoshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

p53 (p53 tumor suppressor); prognosis; RB1 (retinoblastoma tumor suppressor); RB1CC1 (RB1 inducible coiled coil 1); salivary gland cancer

Indexed keywords

CARBOPLATIN; KI 67 ANTIGEN; PROTEIN P53; RB1 INDUCIBLE COILED COIL 1; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA PROTEIN 1; UFT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SALIVARY GLAND CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN-TYROSINE KINASES; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84859766606     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21797     Document Type: Article

References (27)

1. Speight PM, Barrett AW,. Prognostic factors in malignant tumours of the salivary glands. Br J Oral Maxillofac Surg 2009; 47: 587-593.
2. He JF, Ge MH, Zhu X, et al. Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis. Cancer Sci 2008; 99: 1334-1340.
3. Hoang MP, Callender DL, Sola Gallego JJ, et al. Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma. Int J Oncol 2001; 19: 865-871.
4. Batsakis JG, El-Naggar AK,. Myoepithelium in salivary and mammary neoplasms is host-friendly. Adv Anat Pathol 1999; 6: 218-226.
5. Ikebuchi K, Chano T, Ochi Y, et al. RB1CC1 activates the promoter and expression of RB1 in human cancer. Int J Cancer 2009; 125: 861-867.
6. Chano T, Ikegawa S, Kontani K, Okabe H, Baldini N, Saeki Y,. Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene 2002; 21: 1295-1298.
7. Chano T, Ikebuchi K, Ochi Y, et al. RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. PLoS One 2010; 5: e11404.
8. Chano T, Ikebuchi K, Tomita Y, et al. RB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patients. PLoS One 2010; 5: e15737.
9. Barnes L, Eveson JW, Reichart P, Sidransky D,. Pathology and genetics of the head and neck tumors. World Health Organization classification of tumors. Lyon, France: IARC Press; 2005.
10. Ellis GL, Auclair PL,. Tumors of the salivary glands. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology; 1996.
11. Hamper K, Lazar F, Dietel M, et al. Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases. J Oral Pathol Med 1990; 19: 101-107.
12. Guzzo M, Andreola S, Sirizzotti G, Cantu G,. Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol 2002; 9: 688-695.
13. Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001; 25: 835-845.
14. Rapidis AD, Givalos N, Gakiopoulou H, et al. Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. Oral Oncol 2007; 43: 130-136.
15. Szanto PA, Luna MA, Tortoledo ME, White RA,. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 1984; 54: 1062-1069.
16. Ben-Izhak O, Laster Z, Araidy S, Nagler RM,. TUNEL: an efficient prognosis predictor of salivary malignancies. Br J Cancer 2007; 96: 1101-1106.
17. Kishi M, Nakamura M, Nishimine M, Ikuta M, Kirita T, Konishi N,. Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas. Oral Oncol 2005; 41: 161-169.
18. Melkoumian ZK, Peng X, Gan B, Wu X, Guan JL,. Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res 2005; 65: 6676-6684.
19. Hara T, Takamura A, Kishi C, et al. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol 2008; 181: 497-510.
20. Hosokawa N, Hara T, Kaizuka T, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20: 1981-1991.
21. Chan EY,. mTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex. Sci Signal 2009; 2: pe51.
22. Ganley IG, Lam du H, Wang J, Ding X, Chen S, Jiang X,. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 2009; 284: 12297-12305.
23. Hara T, Mizushima N,. Role of ULK-FIP200 complex in mammalian autophagy: FIP200, a counterpart of yeast Atg17? Autophagy 2009; 5: 85-87.
24. Jung CH, Jun CB, Ro SH, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20: 1992-2003.
25. Simon CR, Moda LM, Octacilio-Silva S, Anhezini L, Machado-Gitai LC, Ramos RG,. Precise temporal regulation of roughest is required for correct salivary gland autophagic cell death in Drosophila. Genesis 2009; 47: 492-504.
26. Wilkinson S, Ryan KM,. Autophagy: an adaptable modifier of tumourigenesis. Curr Opin Genet Dev 2010; 20: 57-64.
27. Steeves MA, Dorsey FC, Cleveland JL,. Targeting the autophagy pathway for cancer chemoprevention. Curr Opin Cell Biol 2010; 22: 218-225.